World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 11 January 2021
Main ID:  NCT04655729
Date of registration: 30/11/2020
Prospective Registration: No
Primary sponsor: Massachusetts General Hospital
Public title: Biomarkers to Predict and Monitor Response to Infliximab
Scientific title: Detection of Serum Protein Biomarkers to Predict and Monitor Response to Infliximab Using SOMAscan
Date of first enrolment: November 18, 2019
Target sample size: 120
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT04655729
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
United States
Contacts
Name:     Harland Winter, MD
Address: 
Telephone: 617-724-2004
Email: hwinter@partners.org
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

- Patients between the ages of 3-20 years old

- Patient starting infliximab or infliximab biosimilar,

- Patients naïve to TNF inhibitor

Exclusion Criteria:

- Patients receiving infliximab or biosimilar infusions at home

- Patients already undergone significant bowel surgery relating to their Crohn's.



Age minimum: 3 Years
Age maximum: 20 Years
Gender: All
Health Condition(s) or Problem(s) studied
Crohn Disease
Intervention(s)
Drug: Infliximab
Primary Outcome(s)
Define pretreatment serum protein biomarkers that predict and monitor response to TNF inhibitors (Discovery Cohort) [Time Frame: 2 years]
Secondary Outcome(s)
Identify pathophysiological mechanisms associated with response or lack of response in patients receiving IFX using SOMAscan. [Time Frame: 2 years]
Use systems biology to map out pathways activated in those patients at week 14 that have clinical and laboratory response to infliximab [Time Frame: 2 years]
Secondary ID(s)
2019p002322
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
The Crohn's and Colitis Foundation
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history